期刊文献+

低剂量LPS对PC12细胞抗氧化能力的影响 被引量:2

The effects of low-dose LPS on the anti-oxidant capacity of PC12 cells
下载PDF
导出
摘要 目的:探讨低剂量脂多糖(Lipopolysaccharide,LPS)对PC12细胞抗氧化能力的影响。方法:分别以浓度为0、0.01、0.025、0.05、0.1、0.25、0.5、1μg/μl的LPS刺激PC12细胞24小时,MTT法检测细胞活性确立对细胞没有毒性作用的安全剂量;采用安全剂量刺激PC12细胞24小时,收集培养基上清和细胞,采用试剂盒检测上清中的总抗氧化能力(T-AOC),细胞中超氧化物歧化酶(SOD)的表达,Western blot检测细胞内Bcl-2蛋白的表达;流式细胞仪检测细胞内活性氧(ROS)、钙离子(Ca2+)的平均荧光强度。结果:LPS浓度小于0.1μg/μl对细胞没有明显毒性作用(P〉0.05);采用0、0.01、0.025、0.05、0.1μg/μlLPS分别刺激PC12细胞24小时,培养上清中T-AOC呈下降趋势,以0.05、0.1μg/μl组明显(P〈0.01),细胞内SOD呈上升趋势(0.05μg/μl组,P〈0.05;0.1μg/μl组,P〈0.01),细胞内Bcl-2表达逐渐升高(0.0250.1μg/μl组,P〈0.01),细胞内ROS呈下降趋势(0.1μg/μl组,P〈0.01),钙离子未见明显变化(P〉0.05)。结论:低剂量LPS处理PC12 24小时具有剂量依赖性增强细胞抗氧化能力,并可能藉此参与应激耐受。 Objective:To investigate the effects of low-dose LPS on anti-oxidant capacity in PC12 cells.Methods:Stimulating PC12 cells with various concentrations of LPS(0,0.01,0.025,0.05,0.1,0.25,0.5,1 μg/μl) for 24 h,MTT assay was conducted to establish safe doses for cell viability.Non-lethal doses of LPS were used to deal with PC12 cells for 24 h,the culture supernatant and cells were collected.The total anti-oxidant capacity in culture supernatant and superoxide dismutase in cells were detected with assay kits.The intracellular Bcl-2 protein expressions were detected with Western-blot,and the average fluorescence intensity of ROS and calcium were tested with flow cytometry.Results:Less than 0.1 μg/μl LPS concentration had no toxicity for cell activity(P〉0.05).Stimulating PC12 cells with different concentrations of LPS(0,0.01,0.025,0.05,0.1 μg/μl),the T-AOC decreased significantly,especially in 0.05 μg/μl and 0.1 μg/μl groups(P〈0.01) and the intracellular SOD increased(0.05 μg/μl group,P〈0.05;0.1 μg/μl group,P〈0.01).The Bcl-2 expressions in PC12 cells increased gradually(0.025-0.1 μg/μl group,P〈0.01).The intracellular ROS decreased(0.1 μg/μl group,P〈0.01),but there was no significant changes in calcium(P〉0.05).Conclusion:Low-dose LPS increases PC12 cells' anti-oxidant capacity at 24 h in a dose-dependent manner,and that probably participates in stress tolerance.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第5期430-433,共4页 Chinese Journal of Immunology
关键词 LPS PC12细胞 抗氧化能力 应激耐受 LPS PC12 cells Antioxidant capacity Stress tolerance
  • 相关文献

参考文献15

  • 1Marsh B,Stevens S L,Packard A E et al.Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke:a critical role for IRF3[J].J Neurosci,2009;29(31):9839-9849.
  • 2Rosenzweig H L,Lessov N S,Henshall D C et al.Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice[J].Stroke,2004;35(11):2576-2581.
  • 3李维朝,蒋电明,朱凤臣,祁晓桐.内毒素耐受的分子机制研究进展[J].中国免疫学杂志,2010,26(8):764-768. 被引量:7
  • 4Tasaki K,Ruetzler C A,Ohtsuki T et al.Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats[J].Brain Res,1997;748(1-2):267-270.
  • 5Rosenzweig H L,Lessov N S,Henshall D C et al.Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice[J].Stroke,2004,35(11):2576-2581.
  • 6Rosenzweig H L,Minami M,Lessov N S et al.Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke:a novel role for TNFalpha in LPS-ischemic tolerance[J].J Cereb Blood Flow Metab,2007;27(10):1663-1674.
  • 7Lin H Y,Huang C C,Chang K F.Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat[J].Pediatr Res,2009;66(3):254-259.
  • 8Davis A E,Campbell S J,Wilainam P et al.Post-conditioning with lipopolysaccharide reduces the inflammatory infiltrate to the injured brain and spinal cord:a potential neuroprotective treatment[J].Eur J Neurosci,2005;22(10):2441-2450.
  • 9Innamorato N G,Rojo A I,García-Yagüe A J et al.The transcription factor Nrf2 is a therapeutic target against brain inflammation[J].J Immunol,2008;181(1):680-689.
  • 10Bordet R,Deplanque D,Maboudou P et al.Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance[J].J Cereb Blood Flow Metab,2000;20(8):1190-1196.

二级参考文献52

  • 1张德芹,张建军,钟赣生,王景霞,胡素敏,高学敏.芪蓝糖脂宁胶囊对糖尿病合并高脂血症大鼠肝细胞凋亡及Bax、Bcl-2蛋白表达的影响[J].中华中医药杂志,2005,20(4):211-213. 被引量:24
  • 2徐文岳,吴玉章,王莉,王惠明,王沂芹,赵婷婷,梁云飞,姜曼.SR-A受体参与抑制LPS刺激RAW264.7产生炎症因子[J].第三军医大学学报,2006,28(6):512-514. 被引量:4
  • 3Chang J,Kunkel S L,Chang C H.Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells[J].Proc Natl Acad Sci USA,2009;106 (43):18327-18332.
  • 4Hirata N,Yanagawa Y,Satoh M et al.Dendritic cell-derived TNF-alpha is responsible for development of IL-10-producing CD4+ T cells[J].Cell Immunol,2010;261(1):37-41.
  • 5Chen Y,Jiang G,Yang H R et al.Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27[J].Hepatol,2009;51(3):510-519.
  • 6Lemaitre B,Nicolas E,Michaut L et al.The dorsoventral regulatory gene cassette spfitzle/To11/cactus controls the potent antifungal response in Drosophila adults[J].Cell,1996;86(6):973-983.
  • 7Huang B,Zhao J,Unkeless J C et al.TLR signaling by tumor and immune cells:a double edged sword[J].Oncogene,2008;27(2):218-224.
  • 8Spaner D E,Masellis A.Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia[J].Leukemia,2007;21(1):53-60.
  • 9Sato A,1wasaki A.Induction of antiviral immunity require-Toll like-receptor signaling in both stromal and dendritic cell eompartments[J].Proc Natl Acad Sci USA,2004;101(46):16274-l6279.
  • 10Steinman R M,Hemmi H.Dendritic cells:translating innate to adaptive immunity[J].Curr Top Microbiol Immunol,2006;311:17-58.

共引文献113

同被引文献44

  • 1林晓静,李亚洁,李志梁,罗炳德,谭庆,韩雪琳.高温复合脂多糖应激大鼠血浆MDA、SOD的变化规律[J].第二军医大学学报,2006,27(5):507-509. 被引量:6
  • 2马丽琴,谷振勇,董国凯,李娜,高峰,刘霞,马春玲,丛斌,凌亦凌.CCK-8对LPS诱导大鼠血管平滑肌细胞SOD基因表达及NF-κB活性增高的影响[J].第四军医大学学报,2006,27(20):1851-1855. 被引量:5
  • 3王占海,沈凌鸿,陈向东,李建巍,王献,乔志灏,张宏松,朱容.水飞蓟素对脂多糖性大鼠急性肺损伤的拮抗作用[J].中国病理生理杂志,2007,23(2):280-283. 被引量:18
  • 4Wang XJ,Ye M,Zhang YH,et al. CD200-CD200R regula- tion of microglia activation in the pathogenesis of Parkin son's disease[ J]. J Neuroimmune Pharmacol,2007,2(3 ) : 259 - 264.
  • 5Qian L, Flood PM, Hong JS. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy [J]. J Neural Transm,2010,117 (8) :971 -979.
  • 6Dachsel JC, Farter MJ. LRRK2 and Parkinson disease [ J 1. Arch Neurol,2010,67 (5) :542 - 547.
  • 7Kim B, Yang MS, Choi D, et al. Impaired inflammatory responses in routine Lrrk2-knockdown brain microglia [ J ]. PLoS One, 2012,7 (4) : e34 693.
  • 8Liu JL, Tian DS, Li ZW, et al. Tamoxifen alleviates irradia- tion-induced brain injury by attenuating microglial inflam- matory response in vitro and in vivo [ J ]. Brain Res,2010,1 316:101-111.
  • 9Hao C,Richardson A,Fedoroff S. Macrophage-hke ceils orig- inate from neuroepithelium in culture: characterization and properties of the macrophage-like cells [ J ]. Int J Dev Neu- rosci ,1991,9( 1 ) :1 - 14.
  • 10Marker DF, Puccini JM, Mockus TE, et al. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein [ J ]. J Neurointlammation, 2012,9:261.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部